TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T47215	Cholecystokinin receptor	D06BEP	Chlordiazepoxide	Approved	2712	C16H14ClN3O	299.75	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	D0CP4E	Clonazepam	Approved	2802	C15H10ClN3O3	315.71	C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	D0W2NM	Flunitrazepam	Approved	3380	C16H12FN3O3	313.28	CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	D0N9DS	PMID27607364-Compound-4	Patented	3016	C16H13ClN2O	284.74	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B09UVR	N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-nitro-benzamide	Investigative	14208240	C22H15FN4O4	418.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C4=CC=CC=C4F	IC50 ~ 50000 nM	Poor binder
T47215	Cholecystokinin receptor	B0DOK9	N-[(3S)-5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208273	C28H28FN3O2	457.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4F)C	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B1G4DN	4-Dimethylamino-N-[5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide	Investigative	14208255	C24H21FN4O2	416.4	CN(C)C1=CC=C(C=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4F	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B1JX7R	4-(1H-Indol-3-yl)-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-butyramide	Investigative	14208201	C27H24N4O2	436.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)CCCC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B1YBP6	3-Chloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208253	C22H16ClN3O2	389.8	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC(=CC=C4)Cl	IC50 = 75000 nM	Poor binder
T47215	Cholecystokinin receptor	B23SXR	N-[(3R)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208310	C28H29N3O2	439.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B25GEQ	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-phenyl-3H-1,4-benzodiazepin-2-amine	Investigative	13972377	C30H23FN4	458.5	C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N[C@@H]2CC4=CNC5=CC=CC=C54)C6=CC=CC=C6F	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B2EO8I	4-[(2S,3As,4S)-4-[[(7S)-5,13-dioxo-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepin-7-yl]methyl]-4-hydroxy-2-(2-methylpropyl)-1-oxo-2,3a-dihydroimidazo[1,2-a]indol-3-yl]-4-oxobutanoic acid	Investigative	44301168	C35H33N5O7	635.7	CC(C)C[C@H]1C(=O)N2[C@H](N1C(=O)CCC(=O)O)[C@@](C3=CC=CC=C32)(C[C@H]4C5=NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O	IC50 = 81000 nM	Poor binder
T47215	Cholecystokinin receptor	B38OGA	3-[2-(1H-Indol-3-yl)ethylamino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	14208238	C25H22N4O	394.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NCCC4=CNC5=CC=CC=C54	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B3O5ZS	(R)-2-Amino-N-((R)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-phenylpropanamide	Investigative	44311988	C25H24N4O2	412.5	CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)[C@@H](CC3=CC=CC=C3)N)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B42PZF	3,5-Dichloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208265	C22H15Cl2N3O2	424.3	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC(=CC(=C4)Cl)Cl	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B43QTS	3-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1-methyl-1-phenylurea	Investigative	44311593	C23H19FN4O2	402.4	CN(C1=CC=CC=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4F	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B4FRJ3	3-Amino-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one	Investigative	15637150	C15H12FN3O	269.27	C1=CC=C2C(=C1)C(=NC(C(=O)N2)N)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B4H2GX	2-Chloro-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208250	C23H18ClN3O2	403.9	CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C3=CC=CC=C3Cl)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B53WLU	5-Bromo-N-[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide	Investigative	14208233	C24H16BrFN4O2	491.3	C1=CC=C2C(=C1)C(=NC(C(=O)N2)NC(=O)C3=CC4=C(N3)C=CC(=C4)Br)C5=CC=CC=C5F	IC50 = 50000 nM	Poor binder
T47215	Cholecystokinin receptor	B57FQY	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepin-2-amine	Investigative	44323354	C24H19FN4	382.4	C1=CC=C2C(=C1)C(=CN2)C[C@@H]3C(=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)N	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B7FU4V	7-Chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	9865694	C24H18ClN3O	399.9	C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=C2C=C(C=C3)Cl)CC4=CNC5=CC=CC=C54	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B7JQ2D	(3R)-3-Amino-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	7216757	C16H15N3O	265.31	CN1C2=CC=CC=C2C(=N[C@H](C1=O)N)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	B7KDI9	N-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-trifluoromethyl-benzamide	Investigative	14208260	C23H16F3N3O2	423.4	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=C(C=C4)C(F)(F)F	IC50 = 65000 nM	Poor binder
T47215	Cholecystokinin receptor	B7R8OT	(3S)-1-Methyl-3-[(cyclohexylcarbonyl)amino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one	Investigative	14208283	C23H25N3O2	375.5	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3CCCCC3)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BA74JE	3-Amino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one	Investigative	4259649	C15H13N3O	251.28	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)N	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BB5AI8	N-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide	Investigative	14208309	C28H29N3O2	439.5	CCCCCC1=CC=C(C=C1)C(=O)N[C@@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BCY5B2	CID 14208299	Investigative	14208299	C23H17BrFN3O2	466.3	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC=CC=C3Br)C4=CC=CC=C4F	IC50 = 70000 nM	Poor binder
T47215	Cholecystokinin receptor	BE29VC	N-[5-(2-Fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-pentyl-benzamide	Investigative	10182876	C28H28FN3O2	457.5	CCCCCC1=CC=C(C=C1)C(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4F)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BE7Q1U	3-Amino-5-(2-fluoro-phenyl)-1-methyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	14423345	C16H14FN3O	283.3	CN1C2=CC=CC=C2C(=NC(C1=O)N)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BFTY26	2-Chloro-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide	Investigative	14208252	C23H18ClN3O2	403.9	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC=CC=C3Cl)C4=CC=CC=C4	IC50 = 83000 nM	Poor binder
T47215	Cholecystokinin receptor	BG41KQ	(7S)-7-[[(2S,3As,4S)-3-ethyl-4-hydroxy-2-(2-methylpropyl)-1-oxo-2,3a-dihydroimidazo[1,2-a]indol-4-yl]methyl]-6,7,7a,8-tetrahydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione	Investigative	44301228	C33H35N5O4	565.7	CCN1[C@H](C(=O)N2[C@H]1[C@@](C3=CC=CC=C32)(C[C@H]4C5NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O)CC(C)C	IC50 = 81000 nM	Poor binder
T47215	Cholecystokinin receptor	BG69FB	(3S)-1-Methyl-3-[(2-methylpropanoyl)amino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one	Investigative	14208280	C20H21N3O2	335.4	CC(C)C(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BH0O8W	N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-pyrrole-2-carboxamide	Investigative	14208213	C20H15FN4O2	362.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)NC(=O)C3=CC=CN3)C4=CC=CC=C4F	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BI31AE	4-[(2S,3As,4S)-4-[[(7S)-5,13-dioxo-6,7,7a,8-tetrahydroquinazolino[3,2-a][1,4]benzodiazepin-7-yl]methyl]-4-hydroxy-2-(2-methylpropyl)-1-oxo-2,3a-dihydroimidazo[1,2-a]indol-3-yl]-4-oxobutanoic acid	Investigative	44301269	C35H35N5O7	637.7	CC(C)C[C@H]1C(=O)N2[C@H](N1C(=O)CCC(=O)O)[C@@](C3=CC=CC=C32)(C[C@H]4C5NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O	IC50 = 54000 nM	Poor binder
T47215	Cholecystokinin receptor	BI82PK	2-[(3R)-3-(1H-Indol-3-ylmethyl)-2-methylimino-1,3-dihydro-1,4-benzodiazepin-5-yl]-N-methylaniline	Investigative	136026564	C26H25N5	407.5	CNC1=CC=CC=C1C2=N[C@@H](C(=NC)NC3=CC=CC=C32)CC4=CNC5=CC=CC=C54	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BISN61	[(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepin-2-yl]cyanamide	Investigative	44323601	C25H18FN5	407.4	C1=CC=C2C(=C1)C(=CN2)C[C@@H]3C(=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F)NC#N	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BJ9KP3	4-Methyl-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]pentanamide	Investigative	14208282	C22H25N3O2	363.5	CC(C)CCC(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BJF56D	4-Tert-Butyl-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208264	C26H25N3O2	411.5	CC(C)(C)C1=CC=C(C=C1)C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BJQ9W6	4-Hydroxy-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208266	C22H17N3O3	371.4	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=C(C=C4)O	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BJS6U7	4-Cyano-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide	Investigative	14208267	C23H16N4O2	380.4	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=C(C=C4)C#N	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BJXS64	2-Iodo-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide	Investigative	14208315	C23H18IN3O2	495.3	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC=CC=C3I)C4=CC=CC=C4	IC50 = 71000 nM	Poor binder
T47215	Cholecystokinin receptor	BKH2P1	1-Methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	613843	C16H14N2O	250.29	CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BLMW82	(3S)-3-Amino-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	Investigative	7216755	C16H15N3O	265.31	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)N)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BM1R6V	3-(1H-Indol-3-yl)-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide	Investigative	14208200	C26H22N4O2	422.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)CCC4=CNC5=CC=CC=C54	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BME5K4	N-(2-Oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-trifluoromethylsulfanyl-benzamide	Investigative	44311626	C23H16F3N3O2S	455.5	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=CC=C(C=C4)SC(F)(F)F	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BMK14W	N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]thiophene-3-carboxamide	Investigative	14208217	C20H14FN3O2S	379.4	C1=CC=C2C(=C1)C(=NC(C(=O)N2)NC(=O)C3=CSC=C3)C4=CC=CC=C4F	IC50 ~ 50000 nM	Poor binder
T47215	Cholecystokinin receptor	BMO2K4	(2R)-2-Amino-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-3-phenylpropanamide	Investigative	44312020	C24H22N4O2	398.5	C1=CC=C(C=C1)C[C@H](C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4)N	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BOE67C	N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-hydroxy-2-phenylacetamide	Investigative	14208206	C23H18FN3O3	403.4	C1=CC=C(C=C1)C(C(=O)NC2C(=O)NC3=CC=CC=C3C(=N2)C4=CC=CC=C4F)O	IC50 = 80000 nM	Poor binder
T47215	Cholecystokinin receptor	BOL09B	5-(2-Fluoro-phenyl)-3-[(1H-indol-2-ylmethyl)-amino]-1,3-dihydro-benzo[e][1,4]diazepin-2-one	Investigative	14208239	C24H19FN4O	398.4	C1=CC=C2C(=C1)C=C(N2)CNC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BPHQ09	[2-(1H-Indol-3-yl)-1-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-ylcarbamoyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	14208197	C31H31N5O4	537.6	CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BQ15CX	2-Chloro-N-methyl-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)benzamide	Investigative	15167811	C24H20ClN3O2	417.9	CN1C2=CC=CC=C2C(=NC(C1=O)N(C)C(=O)C3=CC=CC=C3Cl)C4=CC=CC=C4	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BRY2C9	N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)pyrazine-2-carboxamide	Investigative	5279395	C20H15N5O2	357.4	C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)C4=NC=CN=C4	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BVO3F5	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-methyl-1,3-dihydro-1,4-benzodiazepin-2-imine	Investigative	136026563	C25H21FN4	396.5	CN=C1[C@H](N=C(C2=CC=CC=C2N1)C3=CC=CC=C3F)CC4=CNC5=CC=CC=C54	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BVTZ86	N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]quinazoline-2-carboxamide	Investigative	14208205	C24H16FN5O2	425.4	C1=CC=C2C(=C1)C=NC(=N2)C(=O)NC3C(=O)NC4=CC=CC=C4C(=N3)C5=CC=CC=C5F	IC50 = 80000 nM	Poor binder
T47215	Cholecystokinin receptor	BW64TS	(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-propyl-1,3-dihydro-1,4-benzodiazepin-2-imine	Investigative	136026565	C27H25FN4	424.5	CCCN=C1[C@H](N=C(C2=CC=CC=C2N1)C3=CC=CC=C3F)CC4=CNC5=CC=CC=C54	IC50 = 100000 nM	Poor binder
T47215	Cholecystokinin receptor	BY18TQ	2,2-Dimethyl-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]propanamide	Investigative	14208288	C21H23N3O2	349.4	CC(C)(C)C(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C	IC50 ~ 100000 nM	Poor binder
T47215	Cholecystokinin receptor	D06DTT	RO-054520	Investigative	193319	C16H13FN2O	268.28	CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder